This is a ppt presentation regarding Acute Hyperglycemic Emergencies we face in routine clinical practices and their management
from Harrison's Principles of Medicine and Paul Marino Emergency Management book
By
Dr.V.B.Kasyapa. J
(MD GM)
This document discusses hyperosmolar hyperglycemic state (HHS), also known as hyperosmolar hyperglycemic nonketotic syndrome (HHNK). It defines HHS as a life-threatening emergency characterized by severe hyperglycemia, hyperosmolality, and dehydration without significant ketoacidosis. The document outlines diagnostic features, etiology, symptoms, physical exam findings, complications, differential diagnosis, investigations, and management of HHS.
This document presents a case study of a 15-year-old female patient admitted to the hospital with diabetic ketoacidosis. She has a history of type 1 diabetes and poor compliance with insulin treatment. She presented with vomiting, loose stools, abdominal pain, and decreased urine output. On examination, she was drowsy and had signs of dehydration. Laboratory tests confirmed high blood glucose, ketones in the urine and blood, and metabolic acidosis. She was diagnosed with diabetic ketoacidosis secondary to acute gastroenteritis and poor insulin compliance. Her treatment included intravenous fluids and insulin therapy, along with antibiotics and electrolyte replacement. Her condition gradually improved over the following days.
This document discusses diabetic ketoacidosis (DKA), providing information on its pathophysiology, classification, precipitating factors, signs and symptoms, laboratory investigations, management, and goals of treatment. It classifies DKA as mild, moderate or severe based on plasma glucose, arterial pH, serum bicarbonate, urine ketones, and anion gap. The key aspects of management include fluid resuscitation to restore intravascular volume, insulin therapy to reduce glucose and ketone levels, and potassium supplementation to correct deficiencies. Bicarbonate supplementation is only recommended if the pH is less than 6.9.
This document provides information on diabetic emergencies including diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and hypoglycemia. It defines each condition, describes their pathogenesis and precipitating factors, outlines their clinical features and diagnostic criteria, and provides guidance on management and treatment. DKA is characterized by hyperglycemia, metabolic acidosis, and high ketone levels, while HHS involves severe hyperglycemia, hyperosmolality, and minimal ketosis. Hypoglycemia is defined as a blood glucose level below 3.9 mmol/L. The document emphasizes the need for prompt treatment of these diabetic emergencies.
Hyperglycemic hyperosmolar syndrome for nursingSafad R. Isam
Hyperglycemic hyperosmolar syndrome (HHS) is a serious condition caused by low insulin levels and high blood glucose levels, resulting in excessive thirst, frequent urination, and dehydration. It predominantly affects older adults with type 2 diabetes and is triggered by illnesses that increase insulin demand. HHS is characterized by hyperglycemia, hyperosmolarity, and alterations in mental status without significant ketosis. Treatment involves fluid replacement, electrolyte management, and insulin administration to restore hydration and metabolic balance while closely monitoring for complications. Lifestyle changes and medical management after recovery can help prevent recurrence of HHS.
A 23-year-old female with a 15-year history of type 1 diabetes presents with disturbed consciousness after a normal vaginal delivery without anesthesia. Her vitals show signs of dehydration and metabolic acidosis. Labs reveal high blood glucose, ketones in blood and urine, and a high anion gap metabolic acidosis. The patient is diagnosed with diabetic ketoacidosis (DKA), which requires careful rehydration, insulin therapy, and electrolyte replacement to correct dehydration, hyperglycemia, and acidosis while avoiding complications like cerebral edema.
An arterial blood gas (ABG) analysis measures pH, oxygen, and carbon dioxide levels in arterial blood. It is used to assess respiratory and metabolic function. The document outlines how to perform an ABG, including using a syringe to draw blood from the radial, brachial, or femoral artery. It discusses components measured in an ABG and their normal ranges, as well as factors that can affect results. Common acid-base imbalances like respiratory acidosis and metabolic alkalosis are also summarized, along with their primary and compensatory responses.
This document provides guidelines for the first line management of adult patients with diabetic ketoacidosis (DKA). It discusses the causes and symptoms of DKA and outlines the key steps in treatment, which include fluid resuscitation, insulin therapy, monitoring of electrolytes and pH, and correcting dehydration and acidosis over 24 hours. The guidelines emphasize restoring circulating volume, reducing blood glucose, and correcting electrolyte imbalances to resolve DKA while avoiding potential complications.
This document discusses hyperosmolar hyperglycemic state (HHS), also known as hyperosmolar hyperglycemic nonketotic syndrome (HHNK). It defines HHS as a life-threatening emergency characterized by severe hyperglycemia, hyperosmolality, and dehydration without significant ketoacidosis. The document outlines diagnostic features, etiology, symptoms, physical exam findings, complications, differential diagnosis, investigations, and management of HHS.
This document presents a case study of a 15-year-old female patient admitted to the hospital with diabetic ketoacidosis. She has a history of type 1 diabetes and poor compliance with insulin treatment. She presented with vomiting, loose stools, abdominal pain, and decreased urine output. On examination, she was drowsy and had signs of dehydration. Laboratory tests confirmed high blood glucose, ketones in the urine and blood, and metabolic acidosis. She was diagnosed with diabetic ketoacidosis secondary to acute gastroenteritis and poor insulin compliance. Her treatment included intravenous fluids and insulin therapy, along with antibiotics and electrolyte replacement. Her condition gradually improved over the following days.
This document discusses diabetic ketoacidosis (DKA), providing information on its pathophysiology, classification, precipitating factors, signs and symptoms, laboratory investigations, management, and goals of treatment. It classifies DKA as mild, moderate or severe based on plasma glucose, arterial pH, serum bicarbonate, urine ketones, and anion gap. The key aspects of management include fluid resuscitation to restore intravascular volume, insulin therapy to reduce glucose and ketone levels, and potassium supplementation to correct deficiencies. Bicarbonate supplementation is only recommended if the pH is less than 6.9.
This document provides information on diabetic emergencies including diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and hypoglycemia. It defines each condition, describes their pathogenesis and precipitating factors, outlines their clinical features and diagnostic criteria, and provides guidance on management and treatment. DKA is characterized by hyperglycemia, metabolic acidosis, and high ketone levels, while HHS involves severe hyperglycemia, hyperosmolality, and minimal ketosis. Hypoglycemia is defined as a blood glucose level below 3.9 mmol/L. The document emphasizes the need for prompt treatment of these diabetic emergencies.
Hyperglycemic hyperosmolar syndrome for nursingSafad R. Isam
Hyperglycemic hyperosmolar syndrome (HHS) is a serious condition caused by low insulin levels and high blood glucose levels, resulting in excessive thirst, frequent urination, and dehydration. It predominantly affects older adults with type 2 diabetes and is triggered by illnesses that increase insulin demand. HHS is characterized by hyperglycemia, hyperosmolarity, and alterations in mental status without significant ketosis. Treatment involves fluid replacement, electrolyte management, and insulin administration to restore hydration and metabolic balance while closely monitoring for complications. Lifestyle changes and medical management after recovery can help prevent recurrence of HHS.
A 23-year-old female with a 15-year history of type 1 diabetes presents with disturbed consciousness after a normal vaginal delivery without anesthesia. Her vitals show signs of dehydration and metabolic acidosis. Labs reveal high blood glucose, ketones in blood and urine, and a high anion gap metabolic acidosis. The patient is diagnosed with diabetic ketoacidosis (DKA), which requires careful rehydration, insulin therapy, and electrolyte replacement to correct dehydration, hyperglycemia, and acidosis while avoiding complications like cerebral edema.
An arterial blood gas (ABG) analysis measures pH, oxygen, and carbon dioxide levels in arterial blood. It is used to assess respiratory and metabolic function. The document outlines how to perform an ABG, including using a syringe to draw blood from the radial, brachial, or femoral artery. It discusses components measured in an ABG and their normal ranges, as well as factors that can affect results. Common acid-base imbalances like respiratory acidosis and metabolic alkalosis are also summarized, along with their primary and compensatory responses.
This document provides guidelines for the first line management of adult patients with diabetic ketoacidosis (DKA). It discusses the causes and symptoms of DKA and outlines the key steps in treatment, which include fluid resuscitation, insulin therapy, monitoring of electrolytes and pH, and correcting dehydration and acidosis over 24 hours. The guidelines emphasize restoring circulating volume, reducing blood glucose, and correcting electrolyte imbalances to resolve DKA while avoiding potential complications.
Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes caused by relative or absolute insulin deficiency that results in hyperglycemia, ketosis, and acidosis. It occurs most often in patients with type 1 diabetes but can also affect those with type 2 diabetes. Treatment of DKA involves fluid resuscitation, intravenous insulin therapy, electrolyte replacement, and monitoring of glucose and acid-base levels until the condition is resolved. Complications can include hypokalemia, hypoglycemia, cerebral edema, and complications related to underlying illnesses. Strict diabetes management and patient education are needed to prevent DKA.
Hyperosmolar hyperglycemic non ketotic coma (HHNC) is a potentially life-threatening complication of type 2 diabetes that occurs when blood glucose levels rise above 50 mmol/L without significant ketosis. It results from severe dehydration caused by sustained osmotic diuresis from chronic hyperglycemia. The key aspects of treatment involve rapid restoration of intravascular volume and circulatory stability through intravenous fluids, followed by administration of insulin to lower blood glucose levels while continuing fluid resuscitation. Vigilant monitoring of fluid balance and electrolytes is also crucial to manage this condition and prevent complications like thromboembolism or cerebral edema during treatment.
CASE PRESENTATION ON HEPATIC ENCEPHALOPATHY DUE TO ALCOHOLISMRahman Khan
- The patient, a 43-year-old male, presented with altered sensorium since the previous evening.
- He has a history of end-stage liver disease and portal hypertension with recurrent hepatic encephalopathy.
- On examination, he appeared drowsy and irritable. Investigations confirmed hepatic encephalopathy.
- He was diagnosed with hepatic encephalopathy due to alcoholism and prescribed medications including cefotaxime, pantoprazole, ondansetron, lactulose, ursodeoxycholic acid, rifaximin, and L-ornithine-L-aspartic acid to treat the condition and its symptoms.
This presentation was present by my friend during emergency posting seminar with Dr.Mohd. Kamal Mohd. Arshad. I upload this ppt here for all of us and my own reference too. Good luck in your life.
This document discusses the assessment and treatment of acute respiratory failure and exacerbations of COPD. It finds that venous blood gases (VBGs) can replace arterial blood gases (ABGs) for initial screening in most COPD exacerbations. For patients with more severe disease and a pH <7.35, an ABG is needed to determine if non-invasive ventilation (NIV) is required. The document provides treatment guidelines including finding and treating the underlying cause, maximum medical therapy such as nebulizers and steroids, and controlled oxygen therapy with repeat ABGs to monitor response and guide need for NIV. It also describes the differences between types 1 and 2 respiratory failure.
Diabetic ketoacidosis is a life-threatening complication of diabetes that occurs when there is not enough insulin in the body. It is characterized by high blood sugars, high ketones, and metabolic acidosis. The main treatment involves fluid replacement, insulin therapy to lower blood sugars and ketones, correcting electrolyte imbalances like potassium, and treating any underlying infections. Complications can include hypokalemia, hypoglycemia, cerebral edema, and pulmonary edema. Patient education focuses on medication adherence, sick-day management, and seeking medical care if symptoms worsen.
Autonomic neuropathy and anesthetic implicationsRichie Sanam
Diabetic patients have increased risk of complications during surgery due to microvascular and macrovascular changes caused by the disease. Autonomic neuropathy is common and affects the cardiovascular, gastrointestinal, genitourinary systems. It is important to assess for autonomic dysfunction preoperatively using tests like heart rate variability, gastric emptying tests, urodynamic studies to guide anesthesia management and reduce risks. Regional anesthesia is preferred over general anesthesia for patients with autonomic neuropathy due to the risk of hypotension, but careful titration is needed to avoid it. Strict glycemic control and protocols to reduce aspiration risk must also be followed in these high risk patients.
The document discusses the differences between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), noting that DKA involves hyperglycemia, ketosis and acidosis while HHS involves severe hyperglycemia and hyperosmolarity without acidosis. It provides details on the pathophysiology, clinical presentation, diagnostic evaluation and treatment approaches for DKA and HHS, emphasizing the goals of treatment as improving circulation, gradually reducing glucose and correcting electrolyte imbalances.
Hypokalemia and hyperkalemia indore pedicon 2014 finalRajesh Kulkarni
This document discusses two case studies of pediatric patients presenting with electrolyte abnormalities. Case 1 involves a 2-year-old boy named Rahul who was brought to the emergency department with diarrhea and dehydration. His lab work showed sodium of 131 mEq/L and potassium of 2 mEq/L, indicating hypokalemia. Case 2 involves a 7-year-old girl named Vinita who was admitted to the PICU for severe diabetic ketoacidosis. Her initial potassium was 4.4 mEq/L but the resident was concerned about potential hyperkalemia with further potassium supplementation. The document then reviews the causes, clinical manifestations, diagnosis, and management of hypo- and hyperkalemia in
This document discusses the use of venous blood gas (VBG) analysis as an alternative to arterial blood gas (ABG) analysis in emergency situations. It finds that VBG measurements of pCO2, pH, and bicarbonate correlate well with ABG measurements and are sufficient to guide treatment for conditions like diabetic ketoacidosis. It also finds that a VBG pCO2 level below 45 mmHg can reliably rule out clinically significant hypercarbia. The vast majority of patients can be managed using VBG alone. An ABG is only needed if the VBG results are discordant with the clinical presentation, such as in hemodynamically unstable patients.
This document provides an overview and guidelines for assessing and managing hypokalemia. It discusses the goals of maintaining potassium balance, causes and clinical manifestations of hypokalemia, approaches to estimating potassium deficit and choosing treatment methods, and considerations for monitoring and follow up. Real case examples are also presented to demonstrate practical application of the guidelines.
Digitalis toxicity is caused by the cardiac glycoside digoxin, which is commonly used to treat heart conditions but has a narrow therapeutic window. Digoxin toxicity can cause various cardiac arrhythmias by inhibiting the sodium-potassium pump in cardiac cells. Management of digoxin toxicity involves supportive care, treating arrhythmias, correcting electrolyte abnormalities, and administering digoxin antibody fragments for severe cases. Symptoms and signs of digoxin toxicity can affect the heart, gastrointestinal system, central nervous system, and vision.
This document discusses the management of hyperkalemia. It begins with a case study of a 77-year-old male presenting with dehydration and unresponsiveness. It then covers the physiology and causes of hyperkalemia, how to evaluate patients for hyperkalemia through history, clinical exam and labs, acute management including calcium, insulin, beta-agonists and loop diuretics, and chronic management including diet, medications and dialysis. The key points are that hyperkalemia can cause life-threatening cardiac issues and needs to be rapidly treated to stabilize the cardiac membrane and shift potassium intracellularly in emergency situations.
This document discusses different types of patient-ventilator dyssynchrony. It begins with background information on how the main purpose of a ventilator is to decrease the work of breathing. Normally, respiratory muscles account for 1-3% of oxygen consumption, but this can increase to 20% for patients in acute respiratory failure undergoing CPR due to the increased work of breathing.
The document then discusses different factors that can contribute to different types of patient-ventilator dyssynchrony, including trigger-related dyssynchrony from a high trigger threshold, muscle weakness, leaks, auto-PEEP, or expiratory flow limitation. Target-related and cycle-related dyssynchrony are also mentioned
Dr. Amish Bhutani discusses diabetic ketoacidosis (DKA), defined as hyperglycemia with metabolic acidosis resulting from insulin deficiency and elevated counter-regulatory hormones. Precipitating events include inadequate insulin, infection, infarction, drugs, pregnancy, and alcohol. Clinical features include nausea, vomiting, abdominal pain, shortness of breath, polydipsia, and lethargy. Management involves IV fluid replacement, insulin therapy, treating the precipitating event, and careful monitoring. Goals are to correct dehydration, metabolic abnormalities, and acidosis while avoiding complications like cerebral edema.
Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes that mainly occurs in patients with type 1 diabetes, but it is not uncommon in some patients with type 2 diabetes. This condition is a complex disordered metabolic state characterized by hyperglycemia, ketoacidosis, and ketonuria.
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are two serious complications of diabetes that represent extremes of the hyperglycemia spectrum. DKA is characterized by hyperglycemia, metabolic acidosis, and ketonemia while HHS features very high blood glucose over 600 mg/dL without significant ketoacidosis. Both require intravenous fluid replacement and insulin therapy. Resolution of DKA requires normalization of acidosis markers and blood glucose under 200 mg/dL while HHS resolution involves blood glucose under 250-300 mg/dL and mental alertness with plasma osmolality under 315 mosmol/kg.
This document discusses organophosphorus poisoning. It covers the types and uses of organophosphates, their metabolism and mechanism of action by inhibiting acetylcholinesterase, and the resulting clinical features. Diagnosis involves looking for a history of exposure and measuring plasma butyrylcholinesterase and red blood cell acetylcholinesterase levels. Treatment consists of atropine to block muscarinic receptors, pralidoxime as a cholinesterase reactivator, and supportive care.
Hypokalemia, or low potassium levels, can have significant effects on muscles, the cardiovascular and nervous systems. It is defined as a potassium level below 3.5 mEq/L. The majority of potassium is found inside cells and is essential for various cellular functions through membrane pumps and channels. Causes of hypokalemia include reduced intake, redistribution into cells, and increased losses through the kidneys or gastrointestinal tract. Treatment focuses on replacing potassium stores through oral or intravenous supplementation, addressing the underlying cause, and preventing further losses and complications like cardiac arrhythmias.
Hypernatremia is defined as a plasma sodium concentration >145 mEq/L. It is usually caused by a water deficit rather than sodium gain. Common causes include impaired thirst, diarrhea, insensible losses from fever/ventilation, and renal losses from osmotic diuresis or diabetes insipidus. Symptoms range from none in chronic cases to neurologic issues like altered mental status. Treatment involves gradually correcting the sodium level by about 10-12 mEq/L/day using oral or IV water while monitoring for complications like cerebral edema. Replacing volume deficits and identifying underlying causes are also important.
Hyponatremia is a common electrolyte abnormality seen in clinical practice. It is defined as a serum sodium level below 135 mmol/L. The main types are isotonic, hypertonic, and hypotonic hyponatremia. Causes include diuretic use, liver cirrhosis, heart failure, and SIADH. Diagnosis involves lab tests and imaging. Management depends on severity and rate of onset, with slow correction for chronic cases to avoid osmotic demyelination syndrome. Fluid restriction and vasopressin antagonists are often used to treat euvolemic hyponatremia.
This document provides an overview of metabolic emergencies that can occur in people with diabetes mellitus, focusing on diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and hypoglycemia. It discusses the diagnostic criteria and pathophysiology of DKA and HHS, as well as their precipitating factors, symptoms, treatment goals, and management including fluid replacement, insulin therapy, electrolyte monitoring and supplementation, and criteria for resolution. Complications of DKA are also reviewed. The document concludes with sections on prevention of DKA and hypoglycemia.
Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes caused by relative or absolute insulin deficiency that results in hyperglycemia, ketosis, and acidosis. It occurs most often in patients with type 1 diabetes but can also affect those with type 2 diabetes. Treatment of DKA involves fluid resuscitation, intravenous insulin therapy, electrolyte replacement, and monitoring of glucose and acid-base levels until the condition is resolved. Complications can include hypokalemia, hypoglycemia, cerebral edema, and complications related to underlying illnesses. Strict diabetes management and patient education are needed to prevent DKA.
Hyperosmolar hyperglycemic non ketotic coma (HHNC) is a potentially life-threatening complication of type 2 diabetes that occurs when blood glucose levels rise above 50 mmol/L without significant ketosis. It results from severe dehydration caused by sustained osmotic diuresis from chronic hyperglycemia. The key aspects of treatment involve rapid restoration of intravascular volume and circulatory stability through intravenous fluids, followed by administration of insulin to lower blood glucose levels while continuing fluid resuscitation. Vigilant monitoring of fluid balance and electrolytes is also crucial to manage this condition and prevent complications like thromboembolism or cerebral edema during treatment.
CASE PRESENTATION ON HEPATIC ENCEPHALOPATHY DUE TO ALCOHOLISMRahman Khan
- The patient, a 43-year-old male, presented with altered sensorium since the previous evening.
- He has a history of end-stage liver disease and portal hypertension with recurrent hepatic encephalopathy.
- On examination, he appeared drowsy and irritable. Investigations confirmed hepatic encephalopathy.
- He was diagnosed with hepatic encephalopathy due to alcoholism and prescribed medications including cefotaxime, pantoprazole, ondansetron, lactulose, ursodeoxycholic acid, rifaximin, and L-ornithine-L-aspartic acid to treat the condition and its symptoms.
This presentation was present by my friend during emergency posting seminar with Dr.Mohd. Kamal Mohd. Arshad. I upload this ppt here for all of us and my own reference too. Good luck in your life.
This document discusses the assessment and treatment of acute respiratory failure and exacerbations of COPD. It finds that venous blood gases (VBGs) can replace arterial blood gases (ABGs) for initial screening in most COPD exacerbations. For patients with more severe disease and a pH <7.35, an ABG is needed to determine if non-invasive ventilation (NIV) is required. The document provides treatment guidelines including finding and treating the underlying cause, maximum medical therapy such as nebulizers and steroids, and controlled oxygen therapy with repeat ABGs to monitor response and guide need for NIV. It also describes the differences between types 1 and 2 respiratory failure.
Diabetic ketoacidosis is a life-threatening complication of diabetes that occurs when there is not enough insulin in the body. It is characterized by high blood sugars, high ketones, and metabolic acidosis. The main treatment involves fluid replacement, insulin therapy to lower blood sugars and ketones, correcting electrolyte imbalances like potassium, and treating any underlying infections. Complications can include hypokalemia, hypoglycemia, cerebral edema, and pulmonary edema. Patient education focuses on medication adherence, sick-day management, and seeking medical care if symptoms worsen.
Autonomic neuropathy and anesthetic implicationsRichie Sanam
Diabetic patients have increased risk of complications during surgery due to microvascular and macrovascular changes caused by the disease. Autonomic neuropathy is common and affects the cardiovascular, gastrointestinal, genitourinary systems. It is important to assess for autonomic dysfunction preoperatively using tests like heart rate variability, gastric emptying tests, urodynamic studies to guide anesthesia management and reduce risks. Regional anesthesia is preferred over general anesthesia for patients with autonomic neuropathy due to the risk of hypotension, but careful titration is needed to avoid it. Strict glycemic control and protocols to reduce aspiration risk must also be followed in these high risk patients.
The document discusses the differences between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), noting that DKA involves hyperglycemia, ketosis and acidosis while HHS involves severe hyperglycemia and hyperosmolarity without acidosis. It provides details on the pathophysiology, clinical presentation, diagnostic evaluation and treatment approaches for DKA and HHS, emphasizing the goals of treatment as improving circulation, gradually reducing glucose and correcting electrolyte imbalances.
Hypokalemia and hyperkalemia indore pedicon 2014 finalRajesh Kulkarni
This document discusses two case studies of pediatric patients presenting with electrolyte abnormalities. Case 1 involves a 2-year-old boy named Rahul who was brought to the emergency department with diarrhea and dehydration. His lab work showed sodium of 131 mEq/L and potassium of 2 mEq/L, indicating hypokalemia. Case 2 involves a 7-year-old girl named Vinita who was admitted to the PICU for severe diabetic ketoacidosis. Her initial potassium was 4.4 mEq/L but the resident was concerned about potential hyperkalemia with further potassium supplementation. The document then reviews the causes, clinical manifestations, diagnosis, and management of hypo- and hyperkalemia in
This document discusses the use of venous blood gas (VBG) analysis as an alternative to arterial blood gas (ABG) analysis in emergency situations. It finds that VBG measurements of pCO2, pH, and bicarbonate correlate well with ABG measurements and are sufficient to guide treatment for conditions like diabetic ketoacidosis. It also finds that a VBG pCO2 level below 45 mmHg can reliably rule out clinically significant hypercarbia. The vast majority of patients can be managed using VBG alone. An ABG is only needed if the VBG results are discordant with the clinical presentation, such as in hemodynamically unstable patients.
This document provides an overview and guidelines for assessing and managing hypokalemia. It discusses the goals of maintaining potassium balance, causes and clinical manifestations of hypokalemia, approaches to estimating potassium deficit and choosing treatment methods, and considerations for monitoring and follow up. Real case examples are also presented to demonstrate practical application of the guidelines.
Digitalis toxicity is caused by the cardiac glycoside digoxin, which is commonly used to treat heart conditions but has a narrow therapeutic window. Digoxin toxicity can cause various cardiac arrhythmias by inhibiting the sodium-potassium pump in cardiac cells. Management of digoxin toxicity involves supportive care, treating arrhythmias, correcting electrolyte abnormalities, and administering digoxin antibody fragments for severe cases. Symptoms and signs of digoxin toxicity can affect the heart, gastrointestinal system, central nervous system, and vision.
This document discusses the management of hyperkalemia. It begins with a case study of a 77-year-old male presenting with dehydration and unresponsiveness. It then covers the physiology and causes of hyperkalemia, how to evaluate patients for hyperkalemia through history, clinical exam and labs, acute management including calcium, insulin, beta-agonists and loop diuretics, and chronic management including diet, medications and dialysis. The key points are that hyperkalemia can cause life-threatening cardiac issues and needs to be rapidly treated to stabilize the cardiac membrane and shift potassium intracellularly in emergency situations.
This document discusses different types of patient-ventilator dyssynchrony. It begins with background information on how the main purpose of a ventilator is to decrease the work of breathing. Normally, respiratory muscles account for 1-3% of oxygen consumption, but this can increase to 20% for patients in acute respiratory failure undergoing CPR due to the increased work of breathing.
The document then discusses different factors that can contribute to different types of patient-ventilator dyssynchrony, including trigger-related dyssynchrony from a high trigger threshold, muscle weakness, leaks, auto-PEEP, or expiratory flow limitation. Target-related and cycle-related dyssynchrony are also mentioned
Dr. Amish Bhutani discusses diabetic ketoacidosis (DKA), defined as hyperglycemia with metabolic acidosis resulting from insulin deficiency and elevated counter-regulatory hormones. Precipitating events include inadequate insulin, infection, infarction, drugs, pregnancy, and alcohol. Clinical features include nausea, vomiting, abdominal pain, shortness of breath, polydipsia, and lethargy. Management involves IV fluid replacement, insulin therapy, treating the precipitating event, and careful monitoring. Goals are to correct dehydration, metabolic abnormalities, and acidosis while avoiding complications like cerebral edema.
Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes that mainly occurs in patients with type 1 diabetes, but it is not uncommon in some patients with type 2 diabetes. This condition is a complex disordered metabolic state characterized by hyperglycemia, ketoacidosis, and ketonuria.
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are two serious complications of diabetes that represent extremes of the hyperglycemia spectrum. DKA is characterized by hyperglycemia, metabolic acidosis, and ketonemia while HHS features very high blood glucose over 600 mg/dL without significant ketoacidosis. Both require intravenous fluid replacement and insulin therapy. Resolution of DKA requires normalization of acidosis markers and blood glucose under 200 mg/dL while HHS resolution involves blood glucose under 250-300 mg/dL and mental alertness with plasma osmolality under 315 mosmol/kg.
This document discusses organophosphorus poisoning. It covers the types and uses of organophosphates, their metabolism and mechanism of action by inhibiting acetylcholinesterase, and the resulting clinical features. Diagnosis involves looking for a history of exposure and measuring plasma butyrylcholinesterase and red blood cell acetylcholinesterase levels. Treatment consists of atropine to block muscarinic receptors, pralidoxime as a cholinesterase reactivator, and supportive care.
Hypokalemia, or low potassium levels, can have significant effects on muscles, the cardiovascular and nervous systems. It is defined as a potassium level below 3.5 mEq/L. The majority of potassium is found inside cells and is essential for various cellular functions through membrane pumps and channels. Causes of hypokalemia include reduced intake, redistribution into cells, and increased losses through the kidneys or gastrointestinal tract. Treatment focuses on replacing potassium stores through oral or intravenous supplementation, addressing the underlying cause, and preventing further losses and complications like cardiac arrhythmias.
Hypernatremia is defined as a plasma sodium concentration >145 mEq/L. It is usually caused by a water deficit rather than sodium gain. Common causes include impaired thirst, diarrhea, insensible losses from fever/ventilation, and renal losses from osmotic diuresis or diabetes insipidus. Symptoms range from none in chronic cases to neurologic issues like altered mental status. Treatment involves gradually correcting the sodium level by about 10-12 mEq/L/day using oral or IV water while monitoring for complications like cerebral edema. Replacing volume deficits and identifying underlying causes are also important.
Hyponatremia is a common electrolyte abnormality seen in clinical practice. It is defined as a serum sodium level below 135 mmol/L. The main types are isotonic, hypertonic, and hypotonic hyponatremia. Causes include diuretic use, liver cirrhosis, heart failure, and SIADH. Diagnosis involves lab tests and imaging. Management depends on severity and rate of onset, with slow correction for chronic cases to avoid osmotic demyelination syndrome. Fluid restriction and vasopressin antagonists are often used to treat euvolemic hyponatremia.
This document provides an overview of metabolic emergencies that can occur in people with diabetes mellitus, focusing on diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and hypoglycemia. It discusses the diagnostic criteria and pathophysiology of DKA and HHS, as well as their precipitating factors, symptoms, treatment goals, and management including fluid replacement, insulin therapy, electrolyte monitoring and supplementation, and criteria for resolution. Complications of DKA are also reviewed. The document concludes with sections on prevention of DKA and hypoglycemia.
- Diabetic ketoacidosis (DKA) is characterized by hyperglycemia, hyperketonemia, and metabolic acidosis due to insulin deficiency. It commonly occurs in type 1 diabetes and can be life-threatening if not treated.
- The pathophysiology involves insulin deficiency leading to hyperglycemia, lipolysis, and ketone body production. This causes dehydration, electrolyte imbalances, and metabolic acidosis. Treatment involves rapid volume expansion, insulin therapy to lower blood glucose levels slowly, and correcting electrolyte and acid-base abnormalities. Close monitoring is needed to prevent complications like cerebral edema.
- Diagnosis is based on hyperglycemia, ketonemia, and metabolic
Uncontrolled blood sugar levels can lead to metabolic emergencies like diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and hypoglycemia in diabetics. DKA and HHS are caused by high blood sugar and result from insulin deficiency, while hypoglycemia is caused by low blood sugar levels. Treatment for these conditions aims to restore fluid and electrolyte balance, lower blood sugar levels, and treat any underlying precipitating causes. Insulin therapy and intravenous fluids are used to treat DKA and HHS, while oral carbohydrates or intravenous dextrose are given for hypoglycemia. Close monitoring of blood sugar, electrolytes, and acid-base status is
This document summarizes diabetic ketoacidosis (DKA), including its diagnosis, pathophysiology, clinical manifestations, treatment goals, and management. DKA is characterized by severe dehydration and electrolyte depletion due to insulin deficiency and increased counterregulatory hormones. Its treatment involves intravenous fluid resuscitation and insulin therapy to correct dehydration, acidosis, and ketosis. Careful monitoring is required to watch for complications like cerebral edema. Recent studies have found subcutaneous insulin and lower-dose intravenous insulin to be effective alternatives to standard intravenous insulin therapy for mild-moderate DKA.
1) Diabetic ketoacidosis and hyperosmolar hyperglycemic state are caused by insulin deficiency and elevation of counterregulatory hormones leading to hyperglycemia and ketonemia. In DKA, lipolysis causes ketone body production while in HHS, insulin is adequate to prevent lipolysis.
2) Diagnosis is based on history, physical exam findings of dehydration and altered mental status, and lab tests showing high blood glucose, ketones, and anion gap metabolic acidosis. Treatment involves fluid resuscitation, insulin therapy to lower blood glucose, and electrolyte replacement.
3) Complications of treatment include hypoglycemia, hypokalemia, and cerebral
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) are acute complications of diabetes that result from insufficient insulin levels. DKA is characterized by high blood glucose, low pH and bicarbonate levels, and ketones in the blood or urine. HHS involves extremely high blood glucose without significant ketosis or acidosis. Treatment for DKA involves rehydration, insulin administration, and correcting electrolyte imbalances. Complications can include hypokalemia, hypoglycemia, and in rare cases cerebral edema in children. Proper patient education aims to prevent DKA episodes.
This document discusses the management of diabetic metabolic emergencies including diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and euglycemic ketoacidosis. It provides details on the diagnostic criteria, precipitating factors, symptoms, treatment principles, and goals of treatment for DKA and HHS. Management of DKA involves fluid resuscitation, insulin therapy, electrolyte replacement, and treating the underlying cause. The goals are to lower ketones and glucose levels at certain hourly rates while maintaining electrolyte and hydration status. Resolution is defined by pH and ketone level normalization. HHS has higher mortality than DKA and involves severe dehydration and hyper
This document provides information on diabetic ketoacidosis (DKA), including its pathophysiology, clinical manifestations, diagnosis, and management. DKA most commonly presents as the first symptom of type 1 diabetes. The main goals of DKA treatment are to correct acidosis, dehydration, and hyperglycemia. Treatment involves intravenous fluid resuscitation and insulin therapy to rehydrate and lower blood glucose levels. Electrolyte imbalances are also addressed. Complications of DKA include cerebral edema, which requires careful monitoring during treatment. Strict protocols are followed to resolve DKA and transition patients to subcutaneous insulin regimens.
Diabetes mellitus, often referred to simply as DIABETES.
Diabetes is a condition in which the body:
Does not produce enough insulin, and/or
Does not properly respond to insulin
Insulin is a hormone produced in the pancreas. Insulin enables cells to absorb glucose in order to turn it into energy.
Type 1 diabetes:
Diagnosed in children and young adults
Previously known as Juvenile Diabetes
Type 2 diabetes:
Typically diagnosed in adulthood
Also found in overweight children
Complications of blood glucose alterations
Hypoglycemia
Hyperglycemia
Ketosis
Acidosis
DKA (Hyperglycemia + Ketosis + Acidosis)
Normal fasting blood glucose level 4-6 mmol/L
definition:
A state of absolute or relative insulin deficiency aggravated by ensuing hyperglycemia, dehydration, and acidosis-producing derangements in intermediary metabolism, including production of serum acetone.
Can occur in both Type I Diabetes and Type II Diabetes
– In type II diabetics with insulin deficiency/dependence
The presenting symptom for ~ 25% of Type I Diabetics.
160,000 Admissions to private hospitals/year
Cost = over 1 billion $ annually
65% = <19 years old
Main cause of death in children with diabetes (approximately 85%)
Cerebral edema in 69%
Hyperosmolar Hyperglycemic State (HHS):
An acute metabolic complication of diabetes mellitus characterized by impaired mental status and elevated plasma osmolality in a patient with hyperglycemia.
Occurs predominately in Type II Diabetics
– A few reports of cases in type I diabetics.
The presenting symptom for 30-40% of Type II diabetics.
Not commonly associated with ketonaemia and acidosis
The biochemical criteria for the diagnosis of DKA3,4
Hyperglycemia - blood glucose greater than 11.1 mmol/L
Ketosis - ketones present in blood and/or urine
Acidosis - pH less than 7.3 and/or
bicarbonate less than 15 mmol/L
DKA is generally categorized by the severity of the acidosis.
MILD – Venous pH less than 7.3 and/or
bicarbonate concentration less than 15 mmol/L
MODERATE – Venous pH less than 7.2 and/or
bicarbonate concentration less than 10 mmol/L
SEVERE – Venous pH less than 7.1 and/or
bicarbonate concentration less than 5 mmol/L
Risk factors:
Age <12 yrs
No first degree diabetic relative
Lower socioeconomic status
High dose glucocorticoids, atypical antipsychotics, diazoxide and some immunosuppresive drugs
Poor access to medical care
Uninsured
Usage of SGLT-2 inhibitor – euglycaemic DKA
SGLT2 inhibitors blunt insulin production in the face of stress hormones leading to increased ketotic metabolism
AETIOLOGY:
No carbohydrate intake
fasting
gastroenteritis
Atkins diet, neonates fed high-fat milk
Prolonged exercise, pregnancy
Lack of insulin activity
onset of diabetes (insufficient secretion)
interruption of insulin delivery in established pt
Increase in insulin resistance
infection, illness, surgery, stress
Alcohol, salicylate ingestion, inborn metabolic errors
Causes:
Stressful precipitating event that results in increased cate
DIABETIC KETOACIDOSIS (DKA):
A state of absolute or relative insulin deficiency aggravated by ensuing hyperglycemia, dehydration, and acidosis-producing derangements in intermediary metabolism, including production of serum acetone.
Can occur in both Type I Diabetes and Type II Diabetes
– In type II diabetics with insulin deficiency/dependence
The presenting symptom for ~ 25% of Type I Diabetics.
Hyperosmolar Hyperglycemic State (HHS): An acute metabolic complication of diabetes mellitus characterized by impaired mental status and elevated plasma osmolality in a patient with hyperglycemia.
Occurs predominately in Type II Diabetics
– A few reports of cases in type I diabetics.
The presenting symptom for 30-40% of Type II diabetics.
Not commonly associated with ketonaemia and acidosis
Classic Triad of DKA:
Hyperglycemia - blood glucose greater than 11.1 mmol/L
Ketosis - ketones present in blood and/or urine
Acidosis - pH less than 7.3 and/or
bicarbonate less than 15 mmol/L
DKA is generally categorized by the severity of the acidosis.
MILD – Venous pH less than 7.3 and/or
bicarbonate concentration less than 15 mmol/L
MODERATE – Venous pH less than 7.2 and/or
bicarbonate concentration less than 10 mmol/L
SEVERE – Venous pH less than 7.1 and/or
bicarbonate concentration less than 5 mmol/L
Risk factors for DKA at onset:
Age <12 yrs
No first degree diabetic relative
Lower socioeconomic status
High dose glucocorticoids, atypical antipsychotics, diazoxide and some immunosuppresive drugs
Poor access to medical care
Uninsured
Usage of SGLT-2 inhibitor – euglycaemic DKA
SGLT2 inhibitors blunt insulin production in the face of stress hormones leading to increased ketotic metabolism
Why do ketones develop?
No carbohydrate intake
fasting
gastroenteritis
Atkins diet, neonates fed high-fat milk
Prolonged exercise, pregnancy
Lack of insulin activity
onset of diabetes (insufficient secretion)
interruption of insulin delivery in established pt
Increase in insulin resistance
infection, illness, surgery, stress
Alcohol, salicylate ingestion, inborn metabolic errors
Causes of DKA/HHS: Stressful precipitating event that results in increased catecholamines, cortisol, glucagon.
Infection (pneumonia, UTI)
Alcohol, drugs
Stroke
Myocardial Infarction
Pancreatitis
Trauma
Medications (steroids, thiazide diuretics)
Non-compliance with insulin
DKA is a complex metabolic state of: hyperglycemia, ketosis, and acidosis
Symptoms include:
Deep, rapid breathing
Fruity breath odor
Very dry mouth
Nausea and vomiting
Lethargy/drowsiness
DKA is life-threatening and needs immediate treatment
Symptoms of DKA/HHS
Polyuria
Polydypsia
Blurred vision
Nausea/Vomiting
Abdominal Pain
Fatigue
Confusion
Obtundation
Physical Examination in DKA/HHS: Hypotension, tachycardia
Kussmaul breathing (deep, labored breaths)
Fruity odor to breath (due to acetone)
Dry mucus membranes
Confusion
Abdominal tenderness
Treatment of DKA:
Fluids and Electrolytes
Fluid replacement
–Restores perfu
Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) are acute complications of diabetes that result from insufficient insulin. DKA is characterized by hyperglycemia, ketosis, and acidosis, while HHS features severe hyperglycemia without ketosis or acidosis. Both require intravenous fluid replacement and insulin therapy. Hypoglycemia is a potential complication of diabetes treatment caused by excessive insulin or insufficient food intake. It can cause neurological symptoms and be life-threatening. Careful glucose monitoring and management of medications and diet are important for preventing hypoglycemia.
This document discusses the diagnosis and management of hyperglycaemic hyperosmolar state (HHS). HHS is characterized by extreme hyperglycemia, hyperosmolality, and dehydration without significant ketosis or acidosis. It mainly affects elderly patients with multiple comorbidities. The goals of treatment are to gradually normalize osmolality and blood glucose while replacing fluid and electrolyte losses. Intravenous fluids and low-dose insulin are used while carefully monitoring for changes in osmolality and glucose levels. Education is also important to prevent future occurrences of HHS or diabetic ketoacidosis.
Diabetes is a condition where the body does not properly process glucose due to lack of insulin or insulin resistance. Diabetic ketoacidosis (DKA) occurs when a lack of insulin causes the body to break down fat and produce ketones, leading to hyperglycemia, ketosis and acidosis. DKA treatment involves rehydration, insulin therapy to lower blood glucose and ketone levels, electrolyte replacement, and identifying/treating the precipitating cause. Complications can include infection, shock, cerebral edema and death if not properly managed. Prevention relies on education about sick day management to avoid DKA during illness.
Diabetes is a condition where the body does not properly process glucose due to lack of insulin or insulin resistance. Diabetic ketoacidosis (DKA) occurs when a lack of insulin causes the body to break down fat and produce ketones, leading to hyperglycemia, ketosis and acidosis. DKA treatment involves rehydration, insulin therapy to lower blood glucose and ketone levels, electrolyte replacement, and identifying/treating the precipitating cause. Complications can include infection, shock, thrombosis, pulmonary edema and cerebral edema. Prevention relies on education about sick day management to avoid DKA during illness.
1. The document discusses disorders of carbohydrate metabolism, focusing on diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS).
2. DKA is characterized by high blood glucose, low pH, and ketones in the blood or urine. HHS involves extremely high blood glucose without acidosis or significant ketones.
3. Treatment for both involves fluid resuscitation, insulin administration, electrolyte replacement, and monitoring for complications. Careful attention must be paid to fluid balance, electrolyte levels, and glucose control during resuscitation.
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are life-threatening emergencies caused by lack of insulin. DKA is characterized by ketosis and acidosis, while HHS involves extreme hyperglycemia and hyperosmolality without significant ketosis. Both require intravenous fluids and insulin to rehydrate the patient and lower blood glucose levels. Complications can include hypoglycemia, cerebral edema, electrolyte imbalances, and death if not properly treated.
general presentation and management of Fluid & Electrolyte.pptxNatnael21
Discussion about physiology of fluid balance in human and clinical presentation and general management principles of major electrolyte abnormality like hypernatremia hyponatremia hyperkalemia and hypokalemia
Similar to Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa (20)
Postpartum blues includes an array of psychiatric manifestations occurring in the period of post-partum, due to hormonal imbalance. Knowing in detail will help for quicker diagnosis and better outcomes.
Prepared in December, 2017.
This document discusses the approach to anemia. It defines anemia as having insufficient red blood cells or hemoglobin to meet physiological needs. Common symptoms include fatigue, shortness of breath, and palpitations. Clinical evaluation involves assessing symptoms to determine the potential cause, such as blood loss, inflammation, or nutritional deficiencies. Laboratory investigations include complete blood count, iron studies, bone marrow examination, and tests for hemolysis. Anemia is classified as hypo-proliferative, maturation disorders, blood loss, or hemolysis. Treatment depends on the underlying cause and may involve iron supplementation, erythropoietin, vitamin B12/folate, or splenectomy.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
2. Severe Hyperglycaemia
• In a Type 1 or 2 DM patient,
– Blood glucose > 16.7 mmol/L [>300 mg/dL]
• It can be manifested as,
– Diabetic Keto Acidosis (DKA)
– Hyperglycaemic Hyperosmolar State (HHS)
• These two entities are a part of disease
continuum, with or without ketonemia
3. • Commonly characterised by,
– Absent/ relative insulin deficiency
– Volume depletion
– Acid base abnormality
• Usually precipitated,
– Infections
– Infarcts
– Other comorbidities
4. DKA – Presentation
• Symptoms may develop over 24 hrs
• May be seen in established diabetes or in a
type 1 DM, as the presenting feature
• Nausea & Vomiting (most prominent)
• Abdominal pain (resembles acute abdomen)
• Cerebral edema (most commonly seen in
children)
11. Lab diagnostics
• Serum glucose
– Moderate to marked elevation
– Sometimes may be below 300 mg/dL
• Serum HCO3
– Usually <10 mmol/L
• Arterial pH
– 6.8 to 7.3 depending upon severity
12. • Potassium
– Total body deficit always present
– d/t acidosis near normal or elevated serum levels
can be seen
• Other electrolytes (Na, P, Cl & Mg)
– Total body deficit
– d/t hypovolemia and hyperglycaemia near normal
levels are seen
– For every 100mg/dL glucose rise there will be 1.6
mEq Na fall in serum is seen
– So, normal serum Na levels indicate dehydration
13. • ↑ BUN d/t hypovolemia
• ↑ Serum creatinine d/t hypovolemia &
interference by acetoacetate in blood tests
• ↑ Lipid profile (TGA, VLDL)
• ↑ Amylase
– Often salivary
– Pancreatic amylase elevated in acute pancreatitis
• ↑ Serum lipase in acute pancreatitis
(confirmation)
14. • ↑ osmolarity but lesser when compared to HHS
• Ketone bodies
– Preferred diagnosis by blood Beta Hydroxybutyrate
– Normally seen is Acetoaetate in urine by nitroprusside
dipsticks
– These may give false positive values in captopril &
penicillamine intake
• Blood glucose levels will not always correlate with
metabolic acidosis
• Mild to severe metabolic acidosis with High
Anion-Gap is present
15. Anion-Gap
• In a metabolic acidosis patient
AG = Na – (Cl + HCO3)
Albumin corrected AG = AG + [2.5 x (4.5 – serum
albumin)]
Normal values 8-10 mEq/L
– To detect underlying acid base deformity
Gap-Gap ratio = (AG excess)/(HCO3 Deficit)
= (AG – 10)/(24 – S.HCO3)
16. • In high AG metabolic acidosis
– GG ratio > 1 (more HCO3 deficit)
• Coexisting hyperchloremic metabolic acidosis
– D/t saline infusion in DKA treatment
– GG ratio = 1
• Pure DKA
– GG ratio < 1 (alkali is added)
• Coexisting metabolic alkalosis
– Uremia with vomiting
– DKA with continuous ryles aspiration/ diuretics
21. Treatment
• Comprehensive flow sheet maintenance
– Vitals
– Input- Output
– Test values
– Treatment
• Fluid replacement
– Change to 0.45% NS after initial 0.9% NS bolus infusions or
initiate with RL to prevent hyperchloremia
22. • Insulin management
– IV insulin is preferred
– In mild cases
• Short acting SC insulin frequent dosing
– IV insulin should be continued until the resolution
of acidosis and ketosis, not merely glucose levels
• Till oral feeds started
• Then half the dose and add long acting SC insulin
according carbohydrate intake
23. • Hyperglycemia improvement
– Acutely, in first 1-2 hrs of treatment,
• Rapid improvement d/t volume replenishment
– Later on
• 75 – 100 mg/dL per hour
• d/t insulin mediated glucose disposal, Decreased hepatic
glucose production, rehydration
– So when 250 mg/dL achieved
• Add 5% glucose to 0.45%NS infusion
• Along with half the IV insulin infusion dose
24. • Ketosis resolution
– ↓ lipolysis
– ↑ peripheral use
– ↓ hepatic production
– ↑ HCO3 regeneration
– BHB converts to Acetoacetate (initial increase in ketone bodies
in nitroprusside based tests)
• Acidosis improvement
– Primarily by hyperchloremia (d/t treatment)
– Principally by Kidney replanishing the HCO3 stores and excreting
chlorine
25. • Hypokalemia during treatment
– Insulin mediated uptake
– Resolution of acidosis
– Urinary loss of potassium salts & organic acids
– Start potassium replacement when urine output is achieved
• HCO3 replacement
– Not necessary, as rapid correction worsens CNS status
– In severe acidosis (<7.0)
• [50mmol NaHCO3 + 200ml sterile water + 10 mmol KCl] per hour for 2
hrs until pH>7
26. • Phosphate and Magnesium replacement
• Only if severe, not routine
• Phosphorous serum level <0.5 mg/dL
0.5 mmol/kg IV infused over 4-6 hr
• Magnesium serum level <0.8mEq/L;
supplements should be given
27. Prognosis
• Mortality (<1%) with early recognition and
prompt treatment
• Often depends on underlying/ precipitating event
severity
• Major non-metabolic complication is Cerebral
edema, most common in children
– No guidelines but avoid over correction of water loss
28. Follow up
• Patient education,
– Symptoms
– Precipitating factors
– Management of concurrent illness
• Patient during illness/ compromised oral intake
– Frequent capillary glucose check up
– If >300 mg/dL, go for urine ketone bodies
– Drink lots of oral fluids
– Continue or increase the insulin
– Seek medical attention
29. HHS
• Common in elderly type 2
• Several weeks of polyuria, weight loss & D oral
intake present, which leads to CNS depression
• Profound, chronic dehydration is the rule
• Absent,
– Nausea, vomiting, abdominal pain & kussumaul
respiration
31. Pathology
• Relative insulin deficiency,
– ↑ hepatic glucose production by glycogenolysis
– ↓ glucose utilisation in periphery
• Inadequate fluid intake
• Hyperglycaemia
• Lower levels of counter regulatory hormones and
FFA, when compared to DKA
32. Lab diagnostics
• Marked hyperglycemia
– Often > 55.5 mmol/L ( > 1000 mg/dL)
• Hyper osmolarity (> 350 mOsm/L)
• Pre renal azotaemia
• Sodium
– Total body deficit,
– Normal or slightly low serum values even with marked
hyperglycemia
• Corrected Na = 1.6 mEq/100 mg/dL rise of serum
glucose + Serum Na
33. • No ketosis/ acidosis
– Small anion gap acidosis may be with lactic
acidosis
– Moderate ketonemia if associated starvation
34. Treatment
• Frequent monitoring is crucial
• Correct the underlying conditions
• Fluid replacement,
– Till hemodynamically unstable
• 1-3 L 0.9% NS over 2-3 hrs (avoid rapid correction)
• If Serum Na >150 mEq/L; use 0.45% NS
– After hemodynamic stability
• Calculated water deficit will be around 9-10 L
• Correct it in 2-3 days @ 200-300 ml/hr
• Use 0.45% NS
35. • Potassium replacement as necessary;
if associated with diuretic intake correct Magnesium also
• Insulin therapy,
– 0.1U/kg IV bolus
– 0.1 U/Kg/hr IV infusion
– Double; if no fall in 1 hr
– Add 5% glucose to half dose infusion; when serum glucose <250 mg/dL
– Continue until oral feeding started
– SC insulin should be started with long acting insulin according carbohydrate
intake
– Discharge with insulin
– At later date change to oral hypoglycemic drugs